New therapies for type 2 diabetes mellitus

Manuel Puig-Domingo, Silvia Pellitero

Research output: Contribution to journalReview articleResearchpeer-review

4 Citations (Scopus)


© 2014 Elsevier España, S.L.U. The increasing prevalence of obesity and type 2 diabetes mellitus (T2DM) has led to a growing interest in the investigation of new therapies. Treatment of T2DM has focused on the insulinopenia and insulin resistance. However, in the last 10 years, new lines of research have emerged for the treatment of T2DM and preclinical studies appear promising. The possibility of using these drugs in combination with other currently available drugs will enhance the antidiabetic effect and promote weight loss with fewer side effects. The data provided by post-marketing monitoring will help us to better understand their safety profile and potential long-term effects on target organs, especially the cardiovascular risk.
Original languageEnglish
Pages (from-to)560-565
JournalMedicina Clinica
Issue number12
Publication statusPublished - 22 Jun 2015


  • Future
  • Treatment
  • Type 2 diabetes mellitus


Dive into the research topics of 'New therapies for type 2 diabetes mellitus'. Together they form a unique fingerprint.

Cite this